Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Ophthalmology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    May 2020
  1. LENT-SCHOCHET D, Yiu G
    Drusen in dense deposit disease: not just age-related macular degeneration.
    Lancet. 2020;395:1726.
    PubMed    


  2. MARINHO PM, Marcos AAA, Romano AC, Nascimento H, et al
    Retinal findings in patients with COVID-19.
    Lancet. 2020 May 12. pii: S0140-6736(20)31014.
    PubMed    


    April 2020
  3. IYER SSR, Jin Z, Seifert RP, Dang NH, et al
    Bilateral pseudohypopyon causing white eyes in a patient with lymphoma.
    Lancet. 2020;395:e74.
    PubMed    


    February 2020
  4. LU CW, Liu XF, Jia ZF
    2019-nCoV transmission through the ocular surface must not be ignored.
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30313.
    PubMed    


  5. KEMPS PG, Frank MH
    Football causes orbital trapdoor fracture with restricted eye movement.
    Lancet. 2020;395:370.
    PubMed    


    January 2020
  6. LOTERY A, Sivaprasad S, O'Connell A, Harris RA, et al
    Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:294-303.
    PubMed     Abstract available


  7. RABIOLO A, Bandello F
    Eplerenone is not superior to placebo for chronic central serous chorioretinopathy.
    Lancet. 2020;395:252-253.
    PubMed    


  8. DAY AC, Findl O
    Femtosecond laser-assisted vs conventional cataract surgery.
    Lancet. 2020;395:170-171.
    PubMed    


  9. SCHWEITZER C, Brezin A, Cochener B, Monnet D, et al
    Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial.
    Lancet. 2020;395:212-224.
    PubMed     Abstract available


    November 2019
  10. KISCHKA U
    Stroke: the doctor as patient.
    Lancet. 2019;394:1984-1985.
    PubMed    


  11. CHAUVIN A, Bourges JL, Korobelnik JF, Paques M, et al
    Ocular injuries caused by less-lethal weapons in France.
    Lancet. 2019;394:1616-1617.
    PubMed    


    October 2019
  12. THE LANCET
    A vision for universal eye health.
    Lancet. 2019;394:1388.
    PubMed    


  13. BRUINSTROOP E, Cairo I, Drillenburg P, van Dam PS, et al
    Hypothyroidism to Graves' disease and late appearance of pretibial myxoedema.
    Lancet. 2019;394:1364.
    PubMed    


  14. SILBERMANN E, Bourdette D
    A new era for neuromyelitis optica spectrum disorder.
    Lancet. 2019;394:1304-1305.
    PubMed    


  15. CREE BAC, Bennett JL, Kim HJ, Weinshenker BG, et al
    Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
    Lancet. 2019;394:1352-1363.
    PubMed     Abstract available


    September 2019
  16. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    PubMed    


  17. STAHL A, Lepore D, Fielder A, Fleck B, et al
    Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31344.
    PubMed     Abstract available


    August 2019
  18. NAKKAZI E
    People with albinism in Africa: contending with skin cancer.
    Lancet. 2019;394:553-554.
    PubMed    


  19. THE LANCET
    Fear and uncertainty around Kashmir's future.
    Lancet. 2019;394:542.
    PubMed    


  20. LARTIZIEN R, Schouman T, Raux M, Debelmas A, et al
    Yellow vests protests: facial injuries from rubber bullets.
    Lancet. 2019;394:469-470.
    PubMed    


    July 2019
  21. ROMANO V, Dinsdale M, Kaye S
    Compensating for a shortage of corneal donors after Brexit.
    Lancet. 2019 Jul 5. pii: S0140-6736(19)31099.
    PubMed    


    March 2019
  22. JANUSZEWICZ W, Corrie P, Liu H, Chan J, et al
    A sinister black finding in the stomach.
    Lancet. 2019;393:1149.
    PubMed    


  23. WEINREB RN, Moghimi S
    Prophylactic laser iridotomy in primary angle-closure suspects.
    Lancet. 2019 Mar 13. pii: S0140-6736(18)33059.
    PubMed    


  24. HE M, Jiang Y, Huang S, Chang DS, et al
    Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial.
    Lancet. 2019 Mar 13. pii: S0140-6736(18)32607.
    PubMed     Abstract available


  25. YOUNG JW, Caprioli J
    Laser trabeculoplasty as first-line glaucoma treatment.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32553.
    PubMed    


  26. GAZZARD G, Konstantakopoulou E, Garway-Heath D, Garg A, et al
    Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32213.
    PubMed     Abstract available


    January 2019
  27. CHEKHCHAR M, Hajji I, Madiq B, Darfaoui Z, et al
    Mitral stenosis found after eye problem.
    Lancet. 2019;393:275.
    PubMed    


    November 2018
  28. CAMPBELL-YEO M, Benoit B
    Use of morphine before retinopathy of prematurity examinations.
    Lancet. 2018 Nov 30. pii: S0140-6736(18)32324.
    PubMed    


  29. DELL'ARTI L, Plant GT
    Caught on camera: confirmation of choroidal ischaemia causing transient vision loss.
    Lancet. 2018;392:e13.
    PubMed    


    October 2018
  30. MAYA Y, Tashimo A, Ota M
    Persistent red and swollen eyelids.
    Lancet. 2018;392:1552.
    PubMed    


  31. BOUSSINESQ M
    A new powerful drug to combat river blindness.
    Lancet. 2018;392:1170-1172.
    PubMed    


    September 2018
  32. MITCHELL P, Liew G, Gopinath B, Wong TY, et al
    Age-related macular degeneration.
    Lancet. 2018;392:1147-1159.
    PubMed     Abstract available


  33. THE LANCET
    Age-related macular degeneration: treatment at what cost?
    Lancet. 2018;392:1090.
    PubMed    


    August 2018
  34. JAIN S, Goyal A, Kumar V
    Lipaemia retinalis in familial chylomicronaemia syndrome.
    Lancet. 2018;392:e7.
    PubMed    


    February 2018
  35. JONAS JB, Aung T, Bourne RR, Bron AM, et al
    Glaucoma - Authors' reply.
    Lancet. 2018;391:740.
    PubMed    


  36. BEN SALEM C, Fathallah N, Zayani H
    Glaucoma.
    Lancet. 2018;391:739-740.
    PubMed    


  37. AL-LABADI L, Gammoh Y, Shehada R, Shahin R, et al
    University students' knowledge of corneal donation and willingness to donate corneas in the occupied Palestinian territory: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S22.
    PubMed     Abstract available


    January 2018

  38. Vision quest: gene therapy for inherited vision loss.
    Lancet. 2018;391:2.
    PubMed    


    November 2017
  39. BROWN DM, Wykoff CC
    Intravitreal aflibercept for proliferative diabetic retinopathy.
    Lancet. 2017;390:2141.
    PubMed    


  40. SIVAPRASAD S, Prevost AT, Vasconcelos J, Riddell A, et al
    Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply.
    Lancet. 2017;390:2141-2142.
    PubMed    


  41. LIU L, Tham YC, Cheng CY
    Intravitreal aflibercept for proliferative diabetic retinopathy.
    Lancet. 2017;390:2140-2141.
    PubMed    


  42. CAMPOCHIARO PA, Heier JS, Kherani S, Le-Halpere A, et al
    Ocular gene therapy for neovascular AMD: a new era? - Authors' reply.
    Lancet. 2017;390:2140.
    PubMed    


  43. CHATZIRALLI IP, Sergentanis TN
    Ocular gene therapy for neovascular AMD: a new era?
    Lancet. 2017;390:2139-2140.
    PubMed    


    November 2016
  44. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: